Vertex Pharmaceuticals Inc (VRTX): Total Assets
$25.64B
As of 2025-12-31
$27.42B
As of 2026-06-30
+12.2%
3-year compound annual growth
+16.9%
5-year compound annual growth
+26.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $25.64B | +13.8% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $22.53B | -0.9% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $22.73B | +25.2% | 2025-02-13, Balance as of period end |
| 2022-12-31 | $18.15B | +35.1% | 2024-02-15, Balance as of period end |
| 2021-12-31 | $13.43B | +14.3% | 2023-02-10, Balance as of period end |
| 2020-12-31 | $11.75B | +41.3% | 2022-02-09, Balance as of period end |
| 2019-12-31 | $8.32B | +33.2% | 2021-02-11, Balance as of period end |
| 2018-12-31 | $6.25B | +76.1% | 2020-02-13, Balance as of period end |
| 2017-12-31 | $3.55B | +22.4% | 2019-02-13, Balance as of period end |
| 2016-12-31 | $2.90B | +15.9% | 2018-02-15, Balance as of period end |
| 2015-12-31 | $2.50B | +7.0% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $2.33B | +0.7% | 2016-02-16, Balance as of period end |
| 2013-12-31 | $2.32B | -16.0% | 2015-02-13, Balance as of period end |
| 2012-12-31 | $2.76B | +25.2% | 2014-02-11, Balance as of period end |
| 2011-12-31 | $2.20B | +27.8% | 2013-03-01, Balance as of period end |
| 2010-12-31 | $1.73B | -11.8% | 2012-02-22, Balance as of period end |
| 2009-12-31 | $1.96B | n/a | 2011-02-17, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $25.64B | +13.8% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $26.37B | -0.6% |
| Viatris Inc (VTRS) | 2025-12-31 | $37.19B | -10.4% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $40.56B | +7.4% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $15.47B | +8.6% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $40.75B | +3.6% |
| Organon & Co. (OGN) | 2025-12-31 | $12.87B | -1.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $8.19B | +38.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
Compare VRTX, BHC, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗